Program (프로그램)
| Time | Title | Speaker |
|---|---|---|
| 10:00 - 10:05 (05') | Opening Remark | Kyu-Sung Lee Director, Research Institute for Future Medicine, Samsung Medical Center |
| 10:05 - 10:10 (05') | Congratulatory address | Seung Woo Park President of Samsung Medical Center |
| 10:10 - 10:15 (05') | Congratulatory address | Soon Koo Baik President of Wonju Severance Christian Hospital |
| 10:15 - 10:20 (05’) | Congratulatory address | Hwang Eui Su Director, Division of Health Industry Policy, Ministry of Health and Welfare |
| 10:20 - 10:30 (10') | K-DEM Station: Current Status and Achievements | Hong Jin Jeon Samsung Medical Center |
| Session 1 | Development and Commercialization of Digital Therapeutics (10:30 ~ 12:35) |
Chair : Hong Jin Jeon, Samsung Medical Center |
| 10:30 - 10:55 (25') | Scaling DTx for mental health to thousands of patients with anxiety disorders - The Sympatient story | Christian Philipp AngernCV Co-Founder, Sympatient |
| 10:55 - 11:20 (25') | Development and Commercialization of Digital Therapeutics for CGM-based Automated Insulin Delivery | Sang Man JinCV Professor, Samsung Medical Center |
| 11:20 - 11:45 (25') | Clinical Application of Digital Therapeutics in Pediatric Allergic Diseases | Kangmo AhnCV Professor, Samsung Medical Center |
| 11:45 - 12:10 (25’) | Go-to-Market strategy of WELT-i (DTx for Insomnia) | Seong-ji KangCV MD, MPH, WELT |
| 12:10 - 12:35 (25') | Move and play, It will Diagnose and Treat MCI | Sang Yeol YongCV Professor, Wonju Severance Christian Hospital |
| 12:35 - 13:30 (55') | Break time / Lunch | |
| Session 2 | Electroceuticals - Paradigm Shift in the Treatment of Chronic/Intractable Diseases (13:30 ~ 15:50) |
Chair : Young Min Shon, Samsung Medical Center |
| 13:30 - 13:55 (25') | NaviNetics, Inc : Bench to Business to Bedside |
Kendall H. Lee, M.D., Ph.D.CV Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics Yoonbae Oh, Ph.D.CV Associate professor, Mayo Clinic & Vice president, NaviNetics |
| 13:55 - 14:20 (25') | Next-Generation Smart DBS and Neuromodulation: Elucidating Mechanism of Action of DBS in Drug Addiction |
Kendall H. Lee, M.D., Ph.D. CV Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics Hojin Shin, Ph.D.CV Assistant Professor, Mayo Clinic |
| 14:20 - 14:45 (25') | Electroceuticals for Ocular Surface Diseases to Promote Nerve Function Recovery | Dong Hui LimCV Professor, Samsung Medical Center |
| 14:45 - 15:10 (25') | Analyzing Digital Biomarker of Neuromuscular Disorders for Personalized Electroceuticals | Hooman LeeCV CEO, EXOSYSTEMS |
| 15:10 - 15:35 (25') | Electroceuticals for Functional Recovery after Spinal Cord Injury | Jung Keun HyunCV Professor, Dankook University Medical Center |
| 15:35 - 15:50 (15’) | Break Time | |
| Session 3 | Successful Market Entry Strategies for Digital & Electronic Therapeutics (15:50 ~ 17:30) | Chair : Woo Seong Huh, Samsung Medical Center |
| 15:50 - 16:10 (20') | DTx Regulation and Successful Case | Young Min HanCV Assistant Director, Ministry of Food and Drug Safety |
| 16:10 - 16:30 (20') | Introduction to Reimbursement Coverage and Pricing Rules for DTx | Yong Woo KimCV CEO, MDREX |
| 16:30 - 16:50 (20') | Application of Decentralized Clinical Trials of Digital Therapeutics | Hae Sook BokCV Team Leader, A-CRO, Samsung Medical Center |
| 16:50 - 17:10 (20') | Case Studies of Support for the Productization of Digital and Electronic Medical Devices | Young-Jin KimCV Principal Researcher, Dept. of R&D, KBIOHEALTH |
| 17:10 - 17:30 (20') | Differences between Digital Healthcare Services, Digital Therapeutics, and Telemedicine and Essential elements for Successful Market entry of Digital Treatment Devices | Changheon OhCV CEO, Foresight Company Co. Ltd. |
| CLOSING | ||
|
10:00 - 10:05 (05') Opening Remark Kyu-Sung Lee (Director, Research Institute for Future Medicine, Samsung Medical Center) |
|
10:05 - 10:10 (05') Congratulatory address Seung Woo Park (President of Wonju Severance Christian Hospital) |
|
10:10 - 10:15 (05') Congratulatory address Soon Koo Baik (President of Wonju Severance Christian Hospital) |
|
10:15 - 10:20 (05’) Congratulatory address Hwang Eui Su (Director, Division of Health Industry Policy, Ministry of Health and Welfare) |
|
10:20 - 10:30 (10') K-DEM Station: Current Status and Achievements Hong Jin Jeon (Samsung Medical Center) |
|
Session 1 Development and Commercialization of Digital Therapeutics (10:30 ~ 12:35) Chair : Hong Jin Jeon, |
|
10:30 - 10:55 (25') Scaling DTx for mental health to thousands of patients with anxiety disorders - The Sympatient story Christian Philipp Angern (Co-Founder, Sympatient)CV |
|
10:55 - 11:20 (25') Development and Commercialization of Digital Therapeutics for CGM-based Automated Insulin Delivery Hong Jin Jeon (CEO, Meditrix/Professor, Samsung Medical Center)CV |
|
11:20 - 11:45 (25') Clinical Application of Digital Therapeutics in Pediatric Allergic Diseases Kangmo Ahn (Professor, Samsung Medical Center)CV |
|
11:45 - 12:10 (25’) Go-to-Market strategy of WELT-i (DTx for Insomnia) Seong-ji Kang (MD, MPH, WELT)CV |
|
12:10 - 12:35 (25') Move and play, It will Diagnose and Treat MCI Sang Yeol Yong (Professor, Wonju Severance Christian Hospital)CV |
|
12:35 - 13:30 (55') Break time / Lunch |
|
Session 2 Electroceuticals - Paradigm Shift in the Treatment of Chronic/Intractable Diseases (13:30 ~ 15:50) Chair : Young Min Shon, |
|
13:30 - 13:55 (25') NaviNetics, Inc : Bench to Business to Bedside Kendall H., M.D., Ph.D., (Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics)CV Yoonbae Oh, Ph.D.(Associate professor, Mayo Clinic & Vice president, NaviNetics)CV |
|
13:55 - 14:20 (25') Next-Generation Smart DBS and Neuromodulation: Elucidating Mechanism of Action of DBS in Drug Addiction Kendall H., M.D., Ph.D., (Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics)CV Hojin Shin, Ph.D. (Assistant Professor, Mayo Clinic)CV |
|
14:20 - 14:45 (25') Electroceuticals for Ocular Surface Diseases to Promote Nerve Function Recovery Dong Hui Lim (Professor, Samsung Medical Center)CV |
|
14:45 - 15:10 (25') Analyzing Digital Biomarker of Neuromuscular Disorders for Personalized Electroceuticals Hooman Lee (CEO, EXOSYSTEMS)CV |
|
15:10 - 15:35 (25') Electroceuticals for Functional Recovery after Spinal Cord Injury Jung Keun Hyun (Professor, Dankook University Medical Center)CV |
|
15:35 - 15:50 (15’) Break Time |
|
Session 3 Successful Market Entry Strategies for Digital & Electronic Therapeutics Chair : Woo Seong Huh |
|
15:50 - 16:10 (20') DTx Regulation and Successful Case Han Young Min (Assistant Director, Ministry of Food and Drug Safety)CV |
|
16:10 - 16:30 (20') Introduction to Reimbursement Coverage and Pricing Rules for DTx Yong Woo Kim (CEO, MDREX)CV |
|
16:30 - 16:50 (20') Application of Decentralized Clinical Trials of Digital Therapeutics Hae Sook Bok (Team Leader, A-CRO, Samsung Medical Center)CV |
|
16:50 - 17:10 (20') Case Studies of Support for the Productization of Digital and Electronic Medical Devices Young-Jin Kim (Principal Researcher, Dept. of R&D, KBIOHEALTH)CV |
|
17:10 - 17:30 (20') Differences between Digital Healthcare Services, Digital Therapeutics, and Telemedicine and Essential elements for Successful Market entry of Digital Treatment Devices Changheon Oh (CEO, Foresight Company Co. Ltd.)CV |
|
17:30 - CLOSING |
| 시간 | 연제 | 연자 |
|---|---|---|
| 10:00 - 10:05 (05') | 인사말 | 이규성 연구부원장 삼성서울병원 |
| 10:05 - 10:10 (05') | 축사 | 박승우 원장 삼성서울병원 |
| 10:10 - 10:15 (05') | 축사 | 백순구 원장 원주세브란스기독병원 |
| 10:15 - 10:20 (05’) | 축사 | 황의수 보건복지부 보건산업정책과장 |
| 10:20 - 10:30 (10') | 삼성서울병원 연구중심병원 3유닛 K-DEM개발 현황 및 성과 | 전홍진 센터장 삼성서울병원 디지털치료연구센터 |
| Session 1 | 디지털치료기기의 개발 및 사업화 (10:30 ~ 12:35) |
좌장 : 전홍진 센터장 삼성서울병원 디지털치료연구센터 |
| 10:30 - 10:55 (25') | Scaling DTx for mental health to thousands of patients with anxiety disorders - The Sympatient story | Christian Philipp AngernCV Co-Founder, Sympatient |
| 10:55 - 11:20 (25') | CGM 기반 자동화된 인슐린 치료 디지털 치료기기 개발 및 사업화 | 진상만 교수CV 삼성서울병원 내분비대사내과 |
| 11:20 - 11:45 (25') | 소아알레르기질환에서의 디지털 치료제의 임상적 적용 | 안강모 교수CV 삼성서울병원 소아청소년과 |
| 11:45 - 12:10 (25') | 불면증 디지털 치료제 WELT-I의 비즈니스 전략 | 강성지 대표CV 웰트 |
| 12:10 - 12:35 (25') | 움직이고 놀며 경도인지장애 치료하기 | 용상열 교수CV 연세대학교 원주세브란스기독병원 재활의학과 |
| 12:35 - 13:30 (55') | Break time / Lunch | |
| Session 2 | 전자약 - 만성/난치성 질환 치료 패러다임의 전환 (13:30 ~ 15:50) |
좌장 : 손영민 연구소장 삼성서울병원 스마트헬스케어연구소 |
| 13:30 - 13:55 (25') | NaviNetics, Inc : Bench to Business to Bedside |
Kendall H. Lee, M.D., Ph.D.CV Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics Yoonbae Oh, Ph.D.CV Associate professor, Mayo Clinic & Vice president, NaviNetics |
| 13:55 - 14:20 (25') | Next-Generation Smart DBS and Neuromodulation: Elucidating Mechanism of Action of DBS in Drug Addiction |
Kendall H. Lee, M.D., Ph.D.CV Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics Hojin Shin, Ph.D.CV Assistant Professor, Mayo Clinic |
| 14:20 - 14:45 (25') | 안구표면질환 신경재생 전자약 기술개발 | 임동희 교수CV 삼성서울병원 안과 |
| 14:45 - 15:10 (25') | 맞춤형 전자약을 위한 근신경계 디지털바이오마커 분석 기술 | 이후만 대표CV 엑소시스템즈 |
| 15:10 - 15:35 (25') | 척수손상 기능회복을 위한 전자약 개발 | 현정근 교수CV 단국대병원 |
| 15:35 - 15:50 (15’) | Q&A / Break Time | |
| Session 3 | 디지털·전자 치료기기의 성공적인 시장진입 전략 (15:50 ~ 17:30) |
좌장: 허우성 연구소장 삼성서울병원 임상의학연구소 |
| 15:50 - 16:10 (20') | 디지털 치료기기 인허가 규제 및 제품화 성공사례 | 한영민 주무관CV 식품의약품안전처 디지털헬스규제지원과 |
| 16:10 - 16:30 (20') | 디지털 치료기기에 적용되는 건강보험 제도 및 절차 소개 | 김용우 대표CV MDREX |
| 16:30 - 16:50 (20') | 디지털치료기기 임상시험 - 분산형 임상시험 솔루션 사례 | 복혜숙 팀장CV 삼성서울병원 A-CRO |
| 16:50 - 17:10 (20') | 디지털·전자 의료기기의 제품화 지원 사례 | 김영진 팀장CV 오송첨단의료산업진흥재단 첨단의료기기개발지원센터 |
| 17:10 - 17:30 (20') | 디지털 헬스케어 서비스, 디지털 치료기기, 원격의료의 차이점과 디지털 치료기기의 성공적 시장진입을 위한 필수 요소 | 오창헌 대표CV 포사이트컴퍼니 |
| CLOSING | ||
|
10:00 - 10:05 (05') 인사말 이규성 연구부원장 (삼성서울병원) |
|
10:05 - 10:10 (05') 축사 박승우 원장 (삼성서울병원) |
|
10:10 - 10:15 (05') 축사 백순구 원장 (원주세브란스기독병원) |
|
10:15 - 10:20 (05’) 축사 (보건복지부) |
|
10:20 - 10:30 (10') 삼성서울병원 연구중심병원 3유닛 K-DEM개발 현황 및 성과 전홍진 센터장 (삼성서울병원 디지털치료연구센터) |
|
Session 1 디지털치료기기의 개발 및 사업화 좌장 : 전홍진 센터장, 삼성서울병원 디지털치료연구센터 |
|
10:30 - 10:55 (25') Scaling DTx for mental health to thousands of patients with anxiety disorders - The Sympatient story Christian Philipp Angern (Co-Founder, Sympatient)CV |
|
10:55 – 11:20 (25') CGM 기반 자동화된 인슐린 치료 디지털 치료기기 개발 및 사업화 진상만 교수 (삼성서울병원 내분비대사내과)CV |
|
11:20 – 11:45 (25') 소아알레르기질환에서의 디지털 치료제의 임상적 적용 안강모 교수 (삼성서울병원 소아청소년과)CV |
|
11:45 - 12:10 (25’) 불면증 디지털 치료제 WELT-I의 비즈니스 전략 강성지 대표 (웰트)CV |
|
12:10 - 12:35 (25') 움직이고 놀며 경도인지장애 치료하기 용상열 교수 (연세대학교 원주세브란스기독병원 재활의학과)CV |
|
12:35 - 13:30 (55') Break time / Lunch |
|
Session 2 전자약 - 만성/난치성 질환 치료 패러다임의 전환 좌장 : 손영민 연구소장, 삼성서울병원 스마트헬스케어연구소 |
|
13:30 – 13:55 (25') NaviNetics, Inc : Bench to Business to Bedside Kendall H. Lee, M.D., Ph.D. (Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics)CV Yoonbae Oh, Ph.D.(Associate professor, Mayo Clinic & Vice president, NaviNetics)CV |
|
13:55 - 14:20 (25') Next-Generation Smart DBS and Neuromodulation: Elucidating Mechanism of Action of DBS in Drug Addiction Kendall H. Lee, M.D., Ph.D. (Professor, Mayo Clinic & Co-CEO, CMO, NaviNetics)CV Ho Jin Shin, Ph.D., (Assistant Professor, Mayo Clinic)CV |
|
14:20 - 14:45 (25') 안구표면질환 신경재생 전자약 기술개발 임동희 교수 (삼성서울병원 안과)CV |
|
14:45 - 15:10 (25') 맞춤형 전자약을 위한 근신경계 디지털바이오마커 분석 기술 이후만 대표 (엑소시스템즈)CV |
|
15:10 - 15:35 (25') 척수손상 기능회복을 위한 전자약 개발 현정근 교수 (단국대학교병원)CV |
|
15:35 – 15:50 (15’) Break Time |
|
Session 3 디지털·전자 치료기기의 성공적인 시장진입 전략 (15:50 ~ 17:30) 좌장: 허우성 연구소장 (삼성서울병원 임상의학연구소) |
|
15:50 - 16:10 (20') 디지털 치료기기 인허가 규제 및 제품화 성공사례 한영민 주무관 (식품의약품안전처 디지털헬스규제지원과)CV |
|
16:10 - 16:30 (20') 디지털 치료기기에 적용되는 건강보험 제도 및 절차 소개 김용우 대표 (MDREX)CV |
|
16:30 - 16:50 (20') 디지털치료기기 임상시험 - 분산형 임상시험 솔루션 사례 복혜숙 팀장 (삼성서울병원 A-CRO)CV |
|
16:50 - 17:10 (20') 정밀 뇌자극 치료를 위한 환자 맞춤형 자극 설계 기술 빈준길 대표 (오송첨단의료산업진흥재단, 첨단의료기기개발지원센터)CV |
|
17:10 - 17:30 (20') 디지털 헬스케어 서비스, 디지털 치료기기, 원격의료의 차이점과 디지털 치료기기의 성공적 시장진입을 위한 필수 요소 오창헌 대표 (포사이트컴퍼니)CV |
|
CLOSING |
Login (강연 시청)